Immunosuppressive agents in adult kidney transplantation in the National Health Service: a model-based economic evaluation.

No Thumbnail Available
Authors
Snowsill, T. M.
Moore, Jason
Mujica Mota, R. E.
Peters, J. L.
Jones-Hughes, T. L.
Huxley, N. J.
Coelho, H. F.
Haasova, M.
Cooper, C.
Lowe, J. A.
Journal
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Type
Journal Article
Publisher
Oxford Academic
Rights
Archived with thanks to Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Immunosuppression is required in kidney transplantation to prevent rejection and prolong graft survival. We conducted an economic evaluation to support England's National Institute for Health and Care Excellence in developing updated guidance on the use of immunosuppression, incorporating new immunosuppressive agents, and addressing changes in pricing and the evidence base.
Citation
Immunosuppressive agents in adult kidney transplantation in the National Health Service: a model-based economic evaluation. 2017, 32 (7):1251-1259 Nephrol. Dial. Transplant.
Note